SynBioBeta Speaker
Lilly Wollman
Synteny
CEO & Co founder
Lilly is the co-founder and CEO of Synteny. Synteny combines frontier AI and frontier biology to solve the "holy-grail" challenge: the law of molecular recognition. Lilly previously was co-head of the Growth Equity platform at Generation Investment Management, the $32 billion AUM investment firm founded by Al Gore and David Blood. Lilly started her career at Goldman Sachs (Fixed Income, Currencies & Commodities) and held leadership positions at Fortress Investment Group and the Baupost Group.Lilly has been a member of the Board of Directors of Sophia Genetics, Andela, Cibo Technologies.Lilly received her BA in Mathematics magna cum laude and Phi Beta Kappa from Dartmouth College, an MBA from INSEAD, an MSc Finance from London Business School and an MPhil in Computational Biology from the University of Cambridge (graduated with distinction). At Cambridge, she worked as a research associate in the Early Cancer Institute (in the lab of Synteny’s scientific co-founder, Jamie Blundell) and completed her thesis focused on generative models of T cell receptors.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
06:17:23:56
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
